Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Pierre Fons"'
Autor:
Pierre Fons, Mark Whittaker, Ian Hunneyball, Antoine Alam, Isabelle Blanc, Françoise Bono, Frédérique Dol-Gleizes, Jean-Pierre Delord, Céleste Lebbé, Maxime Battistella, Philippe Rochaix, Janik Selves, Anne Gomez-Brouchet, Valérie Martin, Jérôme Meneyrol, Dennis Özcelik, Eric Erdociain, David Sibrac, Pierre-Benoit Ancey, Anne Briaux, Gaelle Badet, Pauline Barron, Florence Gaujarengues, Geneviève Gueguen-Dorbes, Virgile Visentin, Mélanie Pichery, Céline Poussereau-Pomié, Florie A. Bertrand, Michael Esquerré, Michael R. Paillasse
supplementary materials & methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aab200c02df34d0037f10e9a77fdaa8
https://doi.org/10.1158/2767-9764.22546302
https://doi.org/10.1158/2767-9764.22546302
Autor:
Pierre Fons, Mark Whittaker, Ian Hunneyball, Antoine Alam, Isabelle Blanc, Françoise Bono, Frédérique Dol-Gleizes, Jean-Pierre Delord, Céleste Lebbé, Maxime Battistella, Philippe Rochaix, Janik Selves, Anne Gomez-Brouchet, Valérie Martin, Jérôme Meneyrol, Dennis Özcelik, Eric Erdociain, David Sibrac, Pierre-Benoit Ancey, Anne Briaux, Gaelle Badet, Pauline Barron, Florence Gaujarengues, Geneviève Gueguen-Dorbes, Virgile Visentin, Mélanie Pichery, Céline Poussereau-Pomié, Florie A. Bertrand, Michael Esquerré, Michael R. Paillasse
Supplementary Figure S8 shows that EVT801 doesn’t modify blood pressure in rat while sorafenib increases it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54437c04f35665bb180f58aab83e2bf2
https://doi.org/10.1158/2767-9764.22546308.v1
https://doi.org/10.1158/2767-9764.22546308.v1
Autor:
Pierre Fons, Mark Whittaker, Ian Hunneyball, Antoine Alam, Isabelle Blanc, Françoise Bono, Frédérique Dol-Gleizes, Jean-Pierre Delord, Céleste Lebbé, Maxime Battistella, Philippe Rochaix, Janik Selves, Anne Gomez-Brouchet, Valérie Martin, Jérôme Meneyrol, Dennis Özcelik, Eric Erdociain, David Sibrac, Pierre-Benoit Ancey, Anne Briaux, Gaelle Badet, Pauline Barron, Florence Gaujarengues, Geneviève Gueguen-Dorbes, Virgile Visentin, Mélanie Pichery, Céline Poussereau-Pomié, Florie A. Bertrand, Michael Esquerré, Michael R. Paillasse
Supplementary Table S2 shows EVT801 metabolite potency and selectivity profile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b6b7b7adb54bd4580df39014d631a7
https://doi.org/10.1158/2767-9764.22546296
https://doi.org/10.1158/2767-9764.22546296
Autor:
Michael R. Paillasse, James Garner, Michael Fitzgerald, Lise Davenne, Pierre-Benoit Ancey, celine Poussereau-Pomie, Michael Esquerre, Gaelle Badet, Joel Tuyaret, Marie Mandron, Philippe Rochaix, Maha Ayyoub, Clara Maria Scarlata, Christine Ménétrier-Caux, Chrsitophe CAUX, Philippe Cassier, Jean-Pierre Delord, Carlos Gomez Roca, Pierre Fons
Publikováno v:
Cancer Research. 82:3203-3203
Introduction: EVT801 is a highly selective small molecule inhibitor of VEGFR3 and acts by inhibiting lymphangiogenesis and tumor angiogenesis in and around the tumor. It has shown compelling activity in a wide range of cancer models and is well-toler
Autor:
Isabella Alt, Robert Shelke, Anna Lobley, Claudia Baumgaertler, Maja Stulic, Pierre Fons, Mark Whittaker, Klaus Hackner, Lucia Dzurillova, Edga Petru, Laudia Hadjari, Judith Lafleur, Josef Singer, Nikolaus Krall, Lukas Hefler, Thorsten Füreder, Christina Taubert, Christophe Boudesco, Andrew Payne, Gregory Ian Vladimer
Publikováno v:
Cancer Research. 82:4150-4150
Background: Adenosine signaling is a key metabolic pathway regulating tumor immunity. The conversion of inflammatory extracellular ATP into immunosuppressive adenosine invokes signaling of the A2a receptor (A2AR) in the tumor microenvironment. This d
Autor:
Carlos Gomez roca, Philippe Cassier, Marie Mandron, Myriam Estrabaut, Nathalie Delesque-Touchard, Adam C. Smith, Amy Klawitter, Leesa Gentry, Pierre Fons, Michael R. Paillasse, Lise Davenne, Michael Fitzgerald, James Garner, Jean-Pierre Delord
Publikováno v:
Cancer Research. 82:CT206-CT206
Introduction: EVT801 is a highly selective, orally available VEGFR3 inhibitor that strongly inhibits angiogenesis without inducing hypoxia, considered one of the main causes of cancer-associated immunosuppression. EVT801 has shown compelling single a
Autor:
Pierre Fons
La vie ne m'apprend rien dévoile le parcours de Vincent, un jeune homme audacieux, à la fois loyal en amour et en amitié. Au fil du temps, il sera confronté aux vicissitudes de la vie, oscillant entre des moments de bonheur intense et les blessur
Abstract 1731: EXS21546, a non-CNS penetrant A2AR-selective antagonist for anti-cancer immunotherapy
Autor:
Emilie Mirey, Florie Bertrand, Andrew Simon Bell, Gregory I. Vladimer, Emilie Pelissier, Isabella Alt, Mark Whittaker, Pierre Fons, Joost van Ham, Stephanie Versluys, Andrew Payne, Michael R. Paillasse, Christina Taubert, Virgile Visentin, Sabrina Pagliarusco
Publikováno v:
Cancer Research. 81:1731-1731
Elevated levels of adenosine found in the tumor microenvironment have been highlighted as a potential mechanism contributing to the restricted efficacy of immune checkpoint inhibitors. While the advent of these inhibitors has brought significant bene
Autor:
Françoise Bono, Jean-Marc Herbert, Dol Frédérique, Cécile Volle-Challier, Geneviève Gueguen-Dorbes, Paul J. Schaeffer, Fabien Geronimi, Joël Tuyaret, Jean-Pascal Herault, Pierre Fons
Publikováno v:
Journal of Cellular Physiology. 230:43-51
Tumor angiogenesis is accompanied by vasculogenesis, which is involved in the differentiation and mobilization of human bone marrow cells. In order to further characterize the role of vasculogenesis in the tumor growth process, the effects of FGF2 on
Autor:
Stephanie Versluys, Pierre Fons, Michael R. Paillasse, Celia bergeaud, Federica Ferigo, Andrew Simon Bell, Richard Cox, Jérémy Besnard, Eric Cogo, Simone Culurgioni, Sean Robinson, Frederic Machet, Sabrina Pagliarusco, Emilie Pelissier, Craig Johnstone, Iva Hopkins-Navratilova, Jerome Menegotto, Emilie Mirey, Michael Esquerre, Joanna Lisztwan, Florie Bertrand, Virgile Visentin, Celine Poussereau-Pomie, Andrew Payne, Adrian Schreyer, Andrew L. Hopkins, Mark Whittaker
Publikováno v:
Cancer Research. 79:519-519
Evotec and Exscientia are collaborating to develop an innovative drug discovery platform for accelerating small molecule development in Immuno-Oncology. The primary focus is to target the immunosuppressive adenosine pathway. We have firstly sought to